CHE Q1 Deep Dive: VITAS Drives Growth, Roto-Rooter Adapts to Higher Marketing Costs

Healthcare services company Chemed Corporation (NYSE:CHE) reported Q1 CY2026 results topping the market’s revenue ...

Chemed Corp (CHE) Q1 2026 Earnings Call Highlights: Strong VITAS Performance Amid Roto-Rooter ...

Chemed Corp (CHE) reports robust growth in VITAS admissions and revenue, while Roto-Rooter faces headwinds from weather disruptions and increased marketing costs.

Chemed Stock Jumps 11% on Q1 Beat, VITAS Hospice Strength and Raised 2026 Outlook

Chemed Corp. shares soared more than 10% in midday trading Friday, climbing to around $424 after the healthcare services ...

Chemed signals 2026 EPS of $24-$24.75 as VITAS raises ADC growth outlook to 4.5%-5.5%

Q1 2026 Management view "VITAS performance during the quarter exceeded even the high end of our expectations," said (CEO, ...